author-photo

Ulrike Seitz

University of Ulm

16

Papers

700

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

3′-[18F]Fluoro-3′-Deoxythymidine ([18F]-FLT) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease

2003 Cancer Research
Show All
- Source
- Cite
- Save
Citations (170)
Intensification of the Conditioning Regimen for Patients with high-risk AML and MDS: 3 year Experience of using an188 Re — Labelled anti — CD 66 Monoclonal Antibody

2003
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell lines

2002 European Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (67)
Kinetic investigations of the electrophilic N.C.A. radioiodination of 2′-deoxyuridine using iodogenTM

2001 Journal of Labelled Compounds and Radiopharmaceuticals
Show All
- Source
- Cite
- Save
Citations (2)
Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation

2001 European Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (38)
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

2001 Blood
Show All
- Source
- Cite
- Save
Citations (154)
In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model.

2001 Cancer Research
Show All
- Source
- Cite
- Save
Citations (22)
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.

2000 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (38)
Radioimmunotherapy with Re-188 labelled anti-CD66 antibody for myeloablation prior to stem cell transplantation in high risk leukemia patients

2000 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation

2000 Blood
Show All
- Source
- Cite
- Save
Citations (1)